Docking protein-1 (DOK1), a tumor suppressor, is frequently downregulated in human tumors such as ovarian cancer, Burkitt lymphoma, head and neck cancer (HNC), chronic lymphocytic leukemia (CLL), lung cancer, and breast cancer [30,31]. Here, DOK1 is linked to breast cancer.